Now showing items 1-3 of 3

    • Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. 

      Sud, A; Jones, ME; Broggio, J; Loveday, C; Torr, B; Garrett, A; Nicol, DL; Jhanji, S; Boyce, SA; Gronthoud, F; Ward, P; Handy, JM; Yousaf, N; Larkin, J; Suh, Y-E; Scott, S; Pharoah, PDP; Swanton, C; Abbosh, C; Williams, M; Lyratzopoulos, G; Houlston, R; Turnbull, C (2020-08)
      <h4>Background</h4>Cancer diagnostics and surgery have been disrupted by the response of health care services to the coronavirus disease 2019 (COVID-19) pandemic. Progression of cancers during delay will impact on patients' ...
    • Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. 

      Sud, A; Torr, B; Jones, ME; Broggio, J; Scott, S; Loveday, C; Garrett, A; Gronthoud, F; Nicol, DL; Jhanji, S; Boyce, SA; Williams, M; Riboli, E; Muller, DC; Kipps, E; Larkin, J; Navani, N; Swanton, C; Lyratzopoulos, G; McFerran, E; Lawler, M; Houlston, R; Turnbull, C (2020-08)
      <h4>Background</h4>During the COVID-19 lockdown, referrals via the 2-week-wait urgent pathway for suspected cancer in England, UK, are reported to have decreased by up to 84%. We aimed to examine the impact of different ...
    • Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers. 

      Smrke, A; Younger, E; Wilson, R; Husson, O; Farag, S; Merry, E; Macklin-Doherty, A; Cojocaru, E; Arthur, A; Benson, C; Miah, AB; Zaidi, S; Gennatas, S; Jones, RL (2020-07)
      <h4>Purpose</h4>Many patients with cancer, often those with rare cancers such as sarcomas, travel long distances to access expert care. The COVID-19 pandemic necessitated widespread changes in delivery of cancer care, ...